# EDGAR Filing Document

**Accession Number:** 0000927066
**File Stem:** 0000927066-26-000035
**Filing Date:** 2026-3
**Character Count:** 7869
**Document Hash:** 82aada541585255ffc457e6368327a38
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000927066-26-000035.hdr.sgml**: 20260317

**ACCESSION NUMBER**: 0000927066-26-000035

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20260315

**FILED AS OF DATE**: 20260317

**DATE AS OF CHANGE**: 20260317

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Waters Kathleen Alyce
- **CENTRAL INDEX KEY:** 0001640409

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-14106
- **FILM NUMBER:** 26761916

**MAIL ADDRESS:**
- **STREET 1:** C/O DAVITA INC.
- **STREET 2:** 2000 16TH STREET
- **CITY:** DENVER
- **STATE:** CO
- **ZIP:** 80202
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** DAVITA INC.
- **CENTRAL INDEX KEY:** 0000927066
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 510354549
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 2000 16TH STREET
- **CITY:** DENVER
- **STATE:** CO
- **ZIP:** 80202
- **BUSINESS PHONE:** 310-536-2668

**MAIL ADDRESS:**
- **STREET 1:** 2000 16TH STREET
- **CITY:** DENVER
- **STATE:** CO
- **ZIP:** 80202

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** DAVITA HEALTHCARE PARTNERS INC.
- **DATE OF NAME CHANGE:** 20121107

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** DAVITA INC
- **DATE OF NAME CHANGE:** 20001005

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** TOTAL RENAL CARE HOLDINGS INC
- **DATE OF NAME CHANGE:** 19950524

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Waters Kathleen Alyce<br><sub>(Last) (First) (Middle)</sub><br>C/O DAVITA INC.<br>2000 16TH STREET<br><sub>(Street)</sub><br>DENVER, CO 80202<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2026-03-15 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_Chief Legal & Pub. Affairs Off_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>DAVITA INC. [ DVA ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock | 2026-03-15 |  | A |  | 3185<sup>(1)</sup> | A | $0 | 158462 | D |  |
| Common Stock | 2026-03-15 |  | F |  | 2457<sup>(2)</sup> | D | $150.72 | 156005 | D |  |
| Common Stock | 2026-03-15 |  | F |  | 26118<sup>(3)</sup> | D | $150.72 | 129887 | D |  |
| Common Stock | 2026-03-15 |  | F |  | 940<sup>(4)</sup> | D | $150.72 | 128947 | D |  |
| Common Stock | 2026-03-15 |  | F |  | 4348<sup>(5)</sup> | D | $150.72 | 124599 | D |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Stock Appreciation Rights | $150.72 | 2026-03-15 |  | A |  | 8610 |  | <sup>(6)</sup> | 2031-03-15 | Common Stock | 8610 | $0 | 8610 | D |  |

---

### Footnotes:

(1) These restricted stock units are scheduled to vest 50% each on March 15, 2029 and March 15, 2030, respectively, subject to the terms and conditions of the applicable award agreement.

(2) Shares withheld from issuance to satisfy tax withholding obligations in connection with the vesting of 4,829 shares, which represents the shares received upon the satisfaction of performance criteria underlying the award of performance stock units relating to the 2025 performance period and granted to the Reporting Person on March 15, 2022.

(3) Shares withheld from issuance to satisfy tax withholding obligations in connection with the vesting of 51,330 shares, which represents the shares received upon the satisfaction of performance criteria underlying the award of performance stock units relating to the 2023 - 2025 performance period and granted to the Reporting Person on March 15, 2023.

(4) Shares withheld from issuance to satisfy tax withholding obligation in connection with the vesting of 1,989 shares, which represents 50% of the restricted stock units granted to the Reporting Person on March 15, 2022.

(5) Shares withheld from issuance to satisfy tax withholding obligation in connection with the vesting of 9,205 shares, which represents 50% of the restricted stock units granted to the Reporting Person on March 15, 2023.

(6) The stock appreciation rights are scheduled to vest 50% each on March 15, 2029 and March 15, 2030, respectively, subject to the terms and conditions of the applicable award agreement.

**Signature:** /s/ Stephanie N. Berberich, Attorney-in-Fact  
**Date:** 2026-03-17

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**